Taylor Morrison Home Corporation (TMHC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$60.35
Price Target
$73.75
Target Range
$69.00 — $80.00
Analyst Rating
Buy
Forward P/E11.4x
Trailing P/E7.8x
Forward PEG0.35
Implied Growth-23.1%
Median Target$73.00
Analyst Spread14.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$69
+14.3%
Consensus
$74
+22.2%
Bull Case
$80
+32.6%
Valuation Model TargetsConfidence: 56/100
Bear$42
Base$66
Bull$122
TMHC Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Taylor Morrison Home Corporation (TMHC) has a Wall Street consensus price target of $73.75, based on estimates from 30 covering analysts. With the stock currently trading at $60.35, this represents a potential upside of +22.2%. The company has a market capitalization of $5.64B.
Analyst price targets range from a low of $69.00 to a high of $80.00, representing a 15% spread in expectations. The median target of $73.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 18 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, TMHC trades at a trailing P/E of 7.8x and forward P/E of 11.4x. The forward PEG ratio of 0.35 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -23.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $65.53, with bear and bull scenarios of $42.42 and $121.64 respectively. Model confidence stands at 56/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Consumer Cyclical stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+16.6%
Avg Forward P/E15.8x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 DHID.R. Horton, Inc. | $43.2B | $149.17 | $163.86 | +9.8% | Hold | 14.0x | 52 |
 LENLennar Corporation | $19.5B | $90.54 | $102.14 | +12.8% | Buy | 14.7x | 50 |
 PHMPulteGroup, Inc. | $23.1B | $120.10 | $141.22 | +17.6% | Hold | 12.0x | 44 |
 TOLToll Brothers, Inc. | $13.4B | $141.60 | $166.75 | +17.8% | Hold | 11.1x | 46 |
 NVRNVR, Inc. | $16.9B | $6091.97 | $7465.33 | +22.5% | Buy | 16.9x | 24 |
 MHOM/I Homes, Inc. | $3.4B | $131.67 | $165.00 | +25.3% | Hold | 10.0x | 10 |
 KBHKB Home | $3.1B | $49.67 | $62.57 | +26.0% | Hold | 15.2x | 43 |
 TPHTri Pointe Homes, Inc. | $4.0B | $46.95 | $47.00 | +0.1% | Hold | 23.3x | 22 |
 CVCOCavco Industries, Inc. | $4.7B | $500.33 | $475.00 | -5.1% | Buy | 21.0x | 2 |
 SKYChampion Homes, Inc. | $4.2B | $75.92 | $106.00 | +39.6% | Buy | 20.1x | 8 |
Upside Potential Comparison
SKYKBHMHONVRTOLPHMLENDHISee TMHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TMHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TMHC vs AMZN
Side-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonTMHC — Frequently Asked Questions
Quick answers to the most common questions about buying TMHC stock.
What is the TMHC stock price target for 2026?
The consensus Wall Street price target for TMHC is $73.75, representing 22.2% upside from the current price of $60.35. With 30 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is TMHC a buy, sell, or hold?
TMHC has a consensus rating of "Buy" based on 30 Wall Street analysts. The rating breakdown is predominantly bullish, with 18 Buy/Strong Buy ratings. The consensus 12-month price target of $73.75 implies 22.2% upside from current levels.
Is TMHC stock overvalued or undervalued?
With a forward P/E of 11.3881x, TMHC trades at a relatively low valuation. The consensus target of $73.75 implies 22.2% appreciation, suggesting meaningful undervaluation.
How high can TMHC stock go?
The most bullish Wall Street analyst has a price target of $80 for TMHC, while the most conservative target is $69. The consensus of $73.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $122 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover TMHC stock?
TMHC is heavily covered by Wall Street, with 30 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the TMHC stock forecast?
The 12-month TMHC stock forecast based on 30 Wall Street analysts shows a consensus price target of $73.75, with estimates ranging from $69 (bear case) to $80 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $66, with bear/bull scenarios of $42/$122.
What is TMHC's fair value based on fundamentals?
Our quantitative valuation model calculates TMHC's fair value at $66 (base case), with a bear case of $42 and bull case of $122. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 56/100.
What is TMHC's forward P/E ratio?
TMHC trades at a forward P/E ratio of 11.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 7.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy TMHC stock?
Wall Street analysts are very optimistic on TMHC, with a "Buy" consensus rating and $73.75 price target (22.2% upside). 18 of 30 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do TMHC price targets vary so much?
TMHC analyst price targets range from $69 to $80, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $73.75 consensus represents the middle ground. Our model's $42-$122 range provides an independent fundamental perspective.